Registry of MIUS for Urolithiasis (ReMIUS-U)

Launched by MARMARA UNIVERSITY · Apr 28, 2024

Keywords

ClinConnect Summary

This is a prospective, observational registry called ReMIUS-U (Registry of Minimally Invasive Urology Society for Urolithiasis Patients) being conducted mainly at Marmara University in Istanbul, Turkey. It collects real-world data on adults and children with urinary stones who are treated with minimally invasive methods—percutaneous nephrolithotomy (PCNL), shock wave lithotripsy (SWL), semi-rigid ureterorenoscopy (URS), or flexible ureterorenoscopy (F-URS). The study tracks details from the operation day and immediate outcomes to longer-term results over up to 10 years, including how long surgeries take, how much radiation is used, how long the laser runs, kidney function after surgery, any complications within 3 months, and whether stones come back or other surgeries are needed later.

People can participate if they have a medical need for urolithiasis treatment and can give informed consent. The registry plans to include both children and adults and collects data only from routine care (not a randomized trial). It is a multi-center project in Turkey, with data kept confidential and focused on safety and long-term stone outcomes. If you join, your preoperative information, what happens during your procedure, and your follow-up results over the coming years will be recorded. The study is led by Marmara University and involves several Turkish universities; at this time, results have not yet been published.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • To have a medical indication for urolithiasis
• • Complete data of treatment and follow-up course
• • Patients with consent
• • Patients \> 18 years-old
• • Patients \< 18 years-old
• Exclusion Criteria:
• • Missing data
• • Patients without consent
• • Not to have a medical indication for urolithiasis treatment
• • To have a contraindication for urolithiasis treatment